CULLENFROST BANKERS INC
For the period ended Sep 30, 2024. Filed Oct 31, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Oct 31, 2024
CFR$158.05+1.8%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| September 30,2024 | December 31,2023 | |
|---|---|---|
| Assets: | ||
| Cash and due from banks | $751,174 | $617,569 |
| Interest-bearing deposits | 8,436,550 | 7,985,057 |
| Federal funds sold | 1,000 | — |
| Resell agreements | 9,650 | 84,650 |
| Total cash and cash equivalents | 9,198,374 | 8,687,276 |
| Securities held to maturity, net of allowance for credit losses of $310 at both September 30, 2024 and December 31, 2023 | 3,569,718 | 3,619,428 |
| Securities available for sale, at estimated fair value | 15,320,043 | 16,578,371 |
| Trading account securities | 32,353 | 31,717 |
| Loans, net of unearned discounts | 20,054,863 | 18,824,251 |
| Less: Allowance for credit losses on loans | (263,129) | (245,996) |
| Net loans | 19,791,734 | 18,578,255 |
| Premises and equipment, net | 1,229,221 | 1,190,033 |
| Accrued interest receivable and other assets | 1,866,650 | 2,159,958 |
| Total assets | $51,008,093 | $50,845,038 |
| Liabilities: | ||
| Deposits: | ||
| Non-interest-bearing demand deposits | $13,953,070 | $14,926,094 |
| Interest-bearing deposits | 27,767,551 | 26,994,474 |
| Total deposits | 41,720,621 | 41,920,568 |
| Federal funds purchased | 22,375 | 14,200 |
| Repurchase agreements | 4,014,037 | 4,127,188 |
| Junior subordinated deferrable interest debentures, net of unamortized issuance costs | 123,170 | 123,127 |
| Subordinated notes, net of unamortized issuance costs | 99,609 | 99,491 |
| Accrued interest payable and other liabilities | 893,075 | 844,017 |
| Total liabilities | 46,872,887 | 47,128,591 |
| Shareholders’ Equity: | ||
| Preferred stock, par value $0.01 per share; 10,000,000 shares authorized; 150,000 Series B shares ($1,000 liquidation preference) issued at September 30, 2024 and December 31, 2023 | 145,452 | 145,452 |
| Common stock, par value $0.01 per share; 210,000,000 shares authorized; 64,404,582 shares issued at both September 30, 2024 and December 31, 2023 | 644 | 644 |
| Additional paid-in capital | 1,065,829 | 1,055,809 |
| Retained earnings | 3,889,387 | 3,657,688 |
| Accumulated other comprehensive income (loss), net of tax | (915,433) | (1,119,219) |
| Treasury stock, at cost; 473,378 shares at September 30, 2024 and 219,295 at December 31, 2023 | (50,673) | (23,927) |
| Total shareholders’ equity | 4,135,206 | 3,716,447 |
| Total liabilities and shareholders’ equity | $51,008,093 | $50,845,038 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.